Australia's largest stock trading and investment forum Australia's #1 stock forum

GMN

25.0%

0.3¢ gold mountain limited

Sorry mate. You are on ignore now.

First 116 Last

Share
Profile

Follow
thecore

3,645 Posts.

283

26/07/24

15:43

Post #: 74935003
Share

Originally posted by amb005: ↑

Great response, obviously you have zero clue, no substance in your rebuttles, you get confronted with conflicts of interests, private companies on the GMN registry that are selling to assets to this company, the same private company has a director from GMN itself and a director with a checkered past from CGB that has been delisted from the ASX.

You maybe now start to realise how stupid it is to accuse posters of trying to downramp to get filled, when the company itself cant get the price to move a tick. Yes Im here mate, alive on the planet with a brain if thats what you mean, but I dont hold, I just enjoy researching. GMN might be good for a trade here and there, but nothing more in my opinon.

View attachment 6343020

I saw capital raise in under 3 months, you say otherwise, so we will soon see who knows what they are talking about. I would say its a NO BRAINER.

Expand

Sorry mate. You are on ignore now.

GMN Price at posting: 0.4¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 66 more messages in this thread...

First 116 Last

Add GMN (ASX) to my watchlist

(20min delay)
Last 0.3¢		Change -0.001(25.0%)		Mkt cap ! $11.72M

Open	High	Low	Value	Volume
0.3¢	0.3¢	0.3¢	$1.2K	400K

Buyers (Bids)

No.	Vol.	Price($)
3	1433332	0.3¢

Sellers (Offers)

Price($)	Vol.	No.
0.4¢	27351908	21

View Market Depth

No.	Vol.	Price($)
1	600000	0.003
33	62427462	0.002
19	85390049	0.001
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.004	26586181	19
0.005	9986656	15
0.006	8184522	8
0.007	5007586	9
0.008	11301757	7

Last trade - 11.28am 04/10/2024 (20 minute delay)

GMN (ASX) Chart

Sorry mate. You are on ignore now.

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Sorry mate. You are on ignore now.

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News